(Q51749858)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Y Wan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Jie Zheng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Abdelbary Elhissi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Zhirong Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

5 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

2220-2233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24595496%20AND%20SRC:MED&resulttype=core&format=json

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Paclitaxel quantification in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Enhanced solubility of paclitaxel using water‐soluble and biocompatible 2‐methacryloyloxyethyl phosphorylcholine polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Long-circulating poly(ethylene glycol)-coated emulsions to target solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Nanotechnological applications in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Block copolymer micelles for drug delivery: design, characterization and biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Protease expression in the supernatant of Chinese hamster ovary cells grown in serum-free culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Changing views of the role of matrix metalloproteinases in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Current status of pH-sensitive liposomes in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Microparticles and nanoparticles for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

To PEGylate or not to PEGylate, that is not the question.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1320-8

Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes

21 January 2018

1 reference

12 December 2020

Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel

1 reference

12 December 2020

A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2

1 reference

12 December 2020

Tissue Inhibitor of Matrix Metalloproteinase-2 Regulates Matrix Metalloproteinase-2 Activation by Modulation of Membrane-type 1 Matrix Metalloproteinase Activity in High and Low Invasive Melanoma Cell Lines

1 reference

12 December 2020

Formation of disulfide bonds in synthetic peptides and proteins

1 reference

12 December 2020

Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration

1 reference

12 December 2020